These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 37837960)

  • 21. Ki-ras codon 12 point and P53 mutations: a molecular examination of the main tumor, liver, portal vein, peripheral arterial blood and para-aortic lymph node in pancreatic cancer.
    Yamaguchi K; Chijiiwa K; Torato N; Kinoshita M; Tanaka M
    Am J Gastroenterol; 2000 Aug; 95(8):1939-45. PubMed ID: 10950039
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Collapsin response mediator protein 4 expression is associated with liver metastasis and poor survival in pancreatic cancer.
    Hiroshima Y; Nakamura F; Miyamoto H; Mori R; Taniguchi K; Matsuyama R; Akiyama H; Tanaka K; Ichikawa Y; Kato S; Kobayashi N; Kubota K; Nagashima Y; Goshima Y; Endo I
    Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S369-78. PubMed ID: 22805864
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Illuminating the immunological landscape: mitochondrial gene defects in pancreatic cancer through a multiomics lens.
    Chi H; Su L; Yan Y; Gu X; Su K; Li H; Yu L; Liu J; Wang J; Wu Q; Yang G
    Front Immunol; 2024; 15():1375143. PubMed ID: 38510247
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Small Nucleolar Noncoding RNA SNORA23, Up-Regulated in Human Pancreatic Ductal Adenocarcinoma, Regulates Expression of Spectrin Repeat-Containing Nuclear Envelope 2 to Promote Growth and Metastasis of Xenograft Tumors in Mice.
    Cui L; Nakano K; Obchoei S; Setoguchi K; Matsumoto M; Yamamoto T; Obika S; Shimada K; Hiraoka N
    Gastroenterology; 2017 Jul; 153(1):292-306.e2. PubMed ID: 28390868
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multi-omics analysis reveals the involvement of origin recognition complex subunit 6 in tumor immune regulation and malignant progression.
    Zhu J; Chen Q; Zeng L; Gao H; Wu T; He Y; Xu J; Pang J; Peng J; Deng Y; Han Y; Yi W
    Front Immunol; 2023; 14():1236806. PubMed ID: 37901236
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Supervised Learning and Multi-Omics Integration Reveals Clinical Significance of Inner Membrane Mitochondrial Protein (IMMT) in Prognostic Prediction, Tumor Immune Microenvironment and Precision Medicine for Kidney Renal Clear Cell Carcinoma.
    Chen CC; Chu PY; Lin HY
    Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37240154
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Multi-omic genetic scores advance disease research.
    Chen C; Han L
    Trends Genet; 2023 Aug; 39(8):600-601. PubMed ID: 37295977
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Function and clinical relevance of RHAMM isoforms in pancreatic tumor progression.
    Choi S; Wang D; Chen X; Tang LH; Verma A; Chen Z; Kim BJ; Selesner L; Robzyk K; Zhang G; Pang S; Han T; Chan CS; Fahey TJ; Elemento O; Du YN
    Mol Cancer; 2019 May; 18(1):92. PubMed ID: 31072393
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Roles of Fyn in pancreatic cancer metastasis.
    Chen ZY; Cai L; Bie P; Wang SG; Jiang Y; Dong JH; Li XW
    J Gastroenterol Hepatol; 2010 Feb; 25(2):293-301. PubMed ID: 19968749
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Metastatic-associated biological properties and differential gene expression profiles in established highly liver and peritoneal metastatic cell lines of human pancreatic cancer.
    Ohno K; Hata F; Nishimori H; Yasoshima T; Yanai Y; Sogahata K; Ezoe E; Tanaka H; Kamiguchi K; Isomura H; Denno R; Sato N; Hirata K
    J Exp Clin Cancer Res; 2003 Dec; 22(4):623-31. PubMed ID: 15053306
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mutant p53 Together with TGFβ Signaling Influence Organ-Specific Hematogenous Colonization Patterns of Pancreatic Cancer.
    Zhong Y; Macgregor-Das A; Saunders T; Whittle MC; Makohon-Moore A; Kohutek ZA; Poling J; Herbst BT; Javier BM; Cope L; Leach SD; Hingorani SR; Iacobuzio-Donahue CA
    Clin Cancer Res; 2017 Mar; 23(6):1607-1620. PubMed ID: 27637888
    [No Abstract]   [Full Text] [Related]  

  • 32. Down-regulation of GEP100 causes increase in E-cadherin levels and inhibits pancreatic cancer cell invasion.
    Xie CG; Wei SM; Chen JM; Xu XF; Cai JT; Chen QY; Jia LT
    PLoS One; 2012; 7(5):e37854. PubMed ID: 22662237
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The patterns and dynamics of genomic instability in metastatic pancreatic cancer.
    Campbell PJ; Yachida S; Mudie LJ; Stephens PJ; Pleasance ED; Stebbings LA; Morsberger LA; Latimer C; McLaren S; Lin ML; McBride DJ; Varela I; Nik-Zainal SA; Leroy C; Jia M; Menzies A; Butler AP; Teague JW; Griffin CA; Burton J; Swerdlow H; Quail MA; Stratton MR; Iacobuzio-Donahue C; Futreal PA
    Nature; 2010 Oct; 467(7319):1109-13. PubMed ID: 20981101
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Yin Yang-1 suppresses invasion and metastasis of pancreatic ductal adenocarcinoma by downregulating MMP10 in a MUC4/ErbB2/p38/MEF2C-dependent mechanism.
    Zhang JJ; Zhu Y; Xie KL; Peng YP; Tao JQ; Tang J; Li Z; Xu ZK; Dai CC; Qian ZY; Jiang KR; Wu JL; Gao WT; Du Q; Miao Y
    Mol Cancer; 2014 May; 13():130. PubMed ID: 24884523
    [TBL] [Abstract][Full Text] [Related]  

  • 35. TGF-beta1 down-regulates ICAM-1 expression and enhances liver metastasis of pancreatic cancer.
    Sawada T; Kimura K; Nishihara T; Onoda N; Teraoka H; Yamashita Y; Yamada N; Yashiro M; Ohira M; Hirakawa K
    Adv Med Sci; 2006; 51():60-5. PubMed ID: 17357279
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Organ-, inflammation- and cancer specific transcriptional fingerprints of pancreatic and hepatic stellate cells.
    Erkan M; Weis N; Pan Z; Schwager C; Samkharadze T; Jiang X; Wirkner U; Giese NA; Ansorge W; Debus J; Huber PE; Friess H; Abdollahi A; Kleeff J
    Mol Cancer; 2010 Apr; 9():88. PubMed ID: 20416094
    [TBL] [Abstract][Full Text] [Related]  

  • 37. miR-29c suppresses pancreatic cancer liver metastasis in an orthotopic implantation model in nude mice and affects survival in pancreatic cancer patients.
    Zou Y; Li J; Chen Z; Li X; Zheng S; Yi D; Zhong A; Chen J
    Carcinogenesis; 2015 Jun; 36(6):676-84. PubMed ID: 25863127
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identifying a baicalein-related prognostic signature contributes to prognosis prediction and tumor microenvironment of pancreatic cancer.
    Zhang C; Lei D; Zhou Y; Zhong T; Li X; Ai W; Zheng B; Liu J; Piao Y; Yan Z; Lai Z
    Front Immunol; 2023; 14():1223650. PubMed ID: 37575248
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Liver-Metastasis-Related Genes are Potential Biomarkers for Predicting the Clinical Outcomes of Patients with Pancreatic Adenocarcinoma.
    Dong Y; Tian J; Yan B; Lv K; Li J; Fu D
    Pathol Oncol Res; 2021; 27():1609822. PubMed ID: 34290570
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Metformin inhibits TGF‑β1‑induced epithelial‑mesenchymal transition and liver metastasis of pancreatic cancer cells.
    Yoshida J; Ishikawa T; Endo Y; Matsumura S; Ota T; Mizushima K; Hirai Y; Oka K; Okayama T; Sakamoto N; Inoue K; Kamada K; Uchiyama K; Takagi T; Naito Y; Itoh Y
    Oncol Rep; 2020 Jul; 44(1):371-381. PubMed ID: 32627027
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.